Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Diabetes, Parkinson's disease
Air pollution increases your risk of Parkinson’s disease by 56%, study finds
Parkinson's disease (PD) affects about 2% of people aged 70 and older. Over the next 20 years, the number of individuals with PD is expected to triple. There are various theories explaining this increase,
Coffee drinking linked to higher heart disease, cancer and Parkinson's disease risk
Trichloroethylene (TCE), a chemical commonly used for decaffeinating coffee, degreasing metal, and dry cleaning clothes, is believed to be contributing to the rise of Parkinson's disease, the world's fastest-growing brain condition.
Exposure to Air Pollution Linked to Increased Risk of Parkinson's Disease
Increased exposure to air pollution in the form of particulate matter with a diameter of 2.5 µm or less (PM2.5) and nitrogen dioxide (NO2) was associated with a higher risk for Parkinson's disease, according to a population-based case-control study in JAMA Network Open.
Some diabetes meds might lower risk of dementia, Parkinson's
A specific class of diabetes drug appears to lower people's risk for dementia and Parkinson's disease, a new study shows.
Could gut problems increase your risk of Parkinson's disease? New research points to yes
A study found that those with upper gastrointestinal damage are 76% more likely to develop Parkinson's disease, signaling a potential paradigm shift in how the disease is studied.
Some Diabetes Drugs May Protect Against Dementia and Parkinson's
Scientists found a 22 percent lower risk of any dementia and Parkinson's among a group taking SGLT2 inhibitors for type 2 diabetes.
Air pollution exposure increases risk for Parkinson's disease
Higher exposure to air pollution increases the risk for Parkinson's disease (PD), according to a study published online Sept. 16 in JAMA Network Open.
Research shows diabetes drug could reduce dementia risk. Here’s how the two diseases may be linked
Some diabetes medications linked to lower dementia, Parkinson's disease risk
Gliflozins, another name for sodium-glucose cotransporter-2 (SGLT2) inhibitors, were the subject of the investigation. By encouraging the kidneys to eliminate sugar from the body through urine, they reduce blood sugar.
22h
How a Colorado Parkinson’s group uses climbing to help stave off effects of the disease
Exercise is known as one of the best weapons in limiting the effects of the disease and creating dopamine that is low for ...
WMNF
2d
USF researcher integral part of FDA’s approval of new Parkinson’s drug
The cause of Parkinson's Disease remains largely unknown, but a new drug could be extremely beneficial to treat symptoms.
Channel NewsAsia Singapore
2d
Do your hands sometimes shake uncontrollably? Is it a sign of Parkinson’s disease or something else?
It could be a medical condition called essential tremor, and a new study by Singapore’s National Neuroscience Institute has ...
1d
New Study Links Gut Health With Parkinson’s Risk—Plus One GI Symptom That Could Be an Early Sign
Have you ever heard of the “gut-brain connection”? It refers to the relationship between our gut microbiome and cognitive ...
McKnight's Long-Term Care News
2d
Study: Exercise eases motor symptoms, fatigue in Parkinson’s
Moderate- or high-intensity exercise can help with Parkinson's disease symptoms like fatigue, a recent study shows.
2d
on MSN
Novel drug molecule could help treat Parkinson's disease in young patients
More than 100,000 Canadians currently live with Parkinson's disease. A novel drug molecule being studied by researchers from ...
News Medical
5d
New microscopy technique detects early Parkinson's disease indicators
Researchers at Tel Aviv University cooperated with three major Israeli medical centers to develop a new method for detecting ...
1d
Optimistic Buy Rating for Gain Therapeutics’ GT-02287 Based on Promising Parkinson’s Disease Treatment Potential
Analyst Jason McCarthy from Maxim Group reiterated a Buy rating on Gain Therapeutics (GANX – Research Report) and keeping the price ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Related topics
Air pollution
United States
ALS
NHS
Lewy body dementia
Feedback